TABLE 1.

Demographic and clinic‐pathological features of the individuals used in this study.

Case	DxAP	Assay	Braak stage	Sex	Age (years)	PMD (hh:mm)	Brain weight (g)	Original fixation	Cause of death
1	AD	IF	VI	F	87	15:30	990	Formaldehyde	Sepsis
2	AD	IF, Q	V	F	80	4:00	910	Formaldehyde	Respiratory infection
3	AD	IF	VI	F	85	2:00	1150	Formaldehyde	Cardiorespiratory arrest
4	AD	IF, Q	VI	M	77	5:00	1330	Formaldehyde	Sepsis of bacterial origin
5	AD	IF, Q	VI	M	77	6:00	1060	Formaldehyde	Acute respiratory infection
6	AD	IF, Q	V	M	75	3:00	1050	Formaldehyde	Multi‐organic failure
7	AD	IF, Q	VI	M	92	6:00	960	Formaldehyde	n.a.
8	AD	WB	VI	M	90	4:30	1070	Frozen no‐fix	Cardiorespiratory arrest
9	AD	WB	V‐VI	F	91	5:00	n.a.	Frozen no‐fix	n.a.
10	AD	WB	VI	F	76	11:10	900	Frozen no‐fix	Cardiorespiratory arrest
11	AD	WB	VI	M	69	2:25	n.a.	Frozen no‐fix	Multi‐organic failure
12	AD	WB	VI	F	67	4:15	n.a.	Frozen no‐fix	Bronchopneumonia
13	NAD	IF	n.a.	F	75	10:30	1050	Formaldehyde	Cardiogenic shock
14	NAD	IF, Q	II	F	81	5:00	1100	Formaldehyde	Multi‐organic failure
15	NAD	IF	II	F	62	2:00	1050	Formaldehyde	Cardiorespiratory arrest
16	NAD	IF, Q	II	M	84	3:00	1400	Formaldehyde	Cardiorespiratory arrest
17	NAD	IF, Q	I	M	53	5:00	1300	Formaldehyde	Cardiorespiratory arrest
18	NAD	IF, Q	I	M	58	6:00	1500	Formaldehyde	Acute myocardial infarction
19	NAD	IF, Q	I	M	63	2:00	1400	Formaldehyde	Cardiorespiratory arrest
20	NAD	WB	II	F	83	7:20	1320	Frozen no‐fix	Intestinal ischemia
21	NAD	WB	n.a.	M	77	10:31	n.a.	Frozen no‐fix	n.a.
22	NAD	WB	n.a.	M	68	4:10	1350	Frozen no‐fix	Sepsis
23	NAD	WB	n.a.	F	82	4:00	800	Frozen no‐fix	Respiratory failure
24	NAD	WB	n.a.	M	68	4:00	1220	Frozen no‐fix	Cardiorespiratory arrest

Abbreviations: AD, Alzheimer's disease; DxAP, neuropathological diagnosis; F, Female; IF, Immunofluorescence; M, Male; n.a., not available; NAD, non‐Alzheimer's disease; PMD, post‐mortem delay; Q, Quantification; WB, Western Blot.